DAY 1 - Friday, 25 October 2019
Welcome and Introduction to EndoBridge 2019
Modern way to visualise pituitary tumors
-
Mark Gurnell
What is new in the diagnosis and management of acromegaly?
-
Sebastian Neggers
Treatment of Cushing disease when surgery fails: Individualized case-based approach
-
Misa Pfeifer
Radiotherapy for pituitary tumors
-
Michael Brada
Over or undertreatment of adrenal insufficiency: current and emerging aspects
-
Eystein Husebye
Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas
-
Gary Hammer
Testosterone therapy in men with hypogonadism
-
Dimitrios Goulis
Hirsutism: Practical approaches to diagnosis and treatment
-
Alessandra Gambineri
DAY 2 - Saturday, 26 October 2019
Autoimmune thyroid disease - mechanistic update
-
Monica Marazuela
Immune check-point inhibitors and endocrine dysfunction
-
Frederic Castinetti
An Update on Gestational Diabetes
-
Marianne Andersen
Inpatient management of hyperglycemia
-
Priyathama Vellanki
SGLT inhibitors and GLP Receptor Agonists: Role in altering natural history of diabetic complications
-
Kathleen Wyne
DAY 3 - Sunday, 27 October 2019
Central mechanisms in control of body weight and their implications for obesity treatment
-
Uberto Pagotto
NASH: Is there a treatment?
-
Stergios Polyzos
How low should LDL be according to guidelines?
-
Connie Newman
Update on hypoparathyroidism
-
Heide Siggelkow
Vitamin D an 2019 update
- Jens Bollerslev
Osteoporosis in relation to pregnancy and lactation
-
Barbara Obermayer-Pietsch
New modalities in the management of osteoporosis
-
Joy Wu
Closing comments and adjourn
